Patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants
Recurrent ischemic stroke and bleedinghard clinical
Patients with atrial fibrillation who suffer a stroke while on NOAC therapy remain at high risk for recurrent ischemic stroke and bleeding, highlighting a need for improved secondary prevention strategies.
Patients suffering a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are at high risk of recurrent ischemic stroke and bleeding. In these patients, further research is needed to improve secondary prevention by investigating the mechanisms of recurrent ischemic stroke and bleeding.
Building similarity graph...
Analyzing shared references across papers
Loading...
Maurizio Paciaroni
Valeria Caso
Giancarlo Agnelli
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
Stroke
Duke University
Brown University
University of Helsinki
Building similarity graph...
Analyzing shared references across papers
Loading...
Paciaroni et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d570ad75589c71d767de32 — DOI: https://doi.org/10.1161/strokeaha.121.038239